EMILY PRZYBYL: Open Payments
NPI 1619359262 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$17,477 in 69 payments from 8 companies in 2025. Trend: 2023 $504 · 2024 $1,873 · 2025 $17,477
Speaker / faculty: $12,285Food & beverage: $2,310Travel & lodging: $2,227Consulting: $655
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 34 | $16,209 |
| Ipsen Biopharmaceuticals, Inc | 3 | $314 |
| ABBVIE INC. | 7 | $251 |
| GlaxoSmithKline, LLC. | 1 | $250 |
| Gilead Sciences, Inc. | 13 | $203 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $150 |
| Novo Nordisk Inc | 3 | $60 |
| Intercept Pharmaceuticals, Inc. | 2 | $39 |
Products named: REZDIFFRA, IQIRVO, MAVYRET, XIFAXAN, Wegovy, OCALIVA, UBRELVY, RINVOQ.
Industry payments across NY — which companies pay providers there.
